Showing results (111-120 of 142) with videos related to

Sort By:
Pageof 15
American Journal of Hematology|May 21, 2019
Robust clinical and laboratory response to hydroxyurea using pharmacokinetically guided dosing for young children with sickle cell anemiaPatrick T McGann, Omar Niss, Min Dong, et al.
Nature|October 3, 2014
Pulmonary macrophage transplantation therapyTakuji Suzuki, Paritha Arumugam, Takuro Sakagami, et al.
Cell Reports Methods|September 15, 2023
Generation of a tyrosine hydroxylase-2A-Cre knockin non-human primate model by homology-directed-repair-biased CRISPR genome editingSho Yoshimatsu, Junko Okahara, Junko Yoshie, et al.
Blood|June 1, 2026
Renin-Angiotensin-Aldosterone System Inhibition Exacerbates Anemia in Sickle Cell DiseaseNajmeh Eskandari, Emma Pappano, Maria Armila D Ruiz, et al.
British Journal of Haematology|July 6, 2021
Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics-guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemiaCharles T Quinn, Omar Niss, Min Dong, et al.
Scientific Reports|February 6, 2020
Left atrial dysfunction in sickle cell anemia is associated with diffuse myocardial fibrosis, increased right ventricular pressure and reduced exercise capacityTarek Alsaied, Omar Niss, Justin T Tretter, et al.
Scientific Reports|March 14, 2020
Author Correction: Left atrial dysfunction in sickle cell anemia is associated with diffuse myocardial fibrosis, increased right ventricular pressure and reduced exercise capacityTarek Alsaied, Omar Niss, Justin T Tretter, et al.
Blood Advances|February 17, 2026
Safety and effectiveness of voxelotor in individuals with sickle cell disease in the RETRO and PROSPECT US registriesBiree Andemariam, Nirmish Shah, William B Ershler, et al.
Blood Advances|April 6, 2026
Cure Sickle Cell Initiative Recommendations on Common Data Elements for Sickle Cell Disease Gene Therapy TrialsSophie Lanzkron, Victoria H Coleman-Cowger, Alexis A Thompson, et al.
Molecular Therapy. Methods & Clinical Development|October 11, 2016
Production and purification of high-titer foamy virus vector for the treatment of leukocyte adhesion deficiencyMd Nasimuzzaman, Danielle Lynn, Rebecca Ernst, et al.
Pageof 15